Page last updated: 2024-08-25

bendamustine hydrochloride and Carcinoma

bendamustine hydrochloride has been researched along with Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernhardt, G; Buschauer, A; Hacker, K; Huber, S; Huettner, JP; König, J1
Chow, KU; Hoelzer, D; Mitrou, PS; Rummel, MJ; Weidmann, E1

Other Studies

2 other study(ies) available for bendamustine hydrochloride and Carcinoma

ArticleYear
Esters of Bendamustine Are by Far More Potent Cytotoxic Agents than the Parent Compound against Human Sarcoma and Carcinoma Cells.
    PloS one, 2015, Volume: 10, Issue:7

    Topics: Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Carcinoma; Cell Line, Tumor; Esters; HEK293 Cells; Humans; Organic Cation Transport Proteins; Organic Cation Transporter 1; Sarcoma

2015
In vitro studies with bendamustine: enhanced activity in combination with rituximab.
    Seminars in oncology, 2002, Volume: 29, Issue:4 Suppl 13

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bendamustine Hydrochloride; Carcinoma; Complement System Proteins; Drug Synergism; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Nitrogen Mustard Compounds; Rituximab; Tumor Cells, Cultured

2002